<VariationArchive VariationID="3244562" VariationName="NC_000023.10:g.(?_123025068)_(123041031_?)del" VariationType="Deletion" Accession="VCV003244562" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-07" DateCreated="2024-06-30" MostRecentSubmission="2024-06-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3403486" VariationID="3244562">
      <GeneList>
        <Gene Symbol="XIAP" FullName="X-linked inhibitor of apoptosis" GeneID="331" HGNC_ID="HGNC:592" Source="calculated" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq25</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="123859708" stop="123913972" display_start="123859708" display_stop="123913972" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="122993661" stop="123047828" display_start="122993661" display_stop="123047828" Strand="+" />
          </Location>
          <OMIM>300079</OMIM>
          <Haploinsufficiency last_evaluated="2022-07-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=XIAP">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-07-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=XIAP">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000023.10:g.(?_123025068)_(123041031_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq25</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" innerStart="123025068" innerStop="123041031" display_start="123025068" display_stop="123041031" variantLength="15964" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.(?_123025068)_(123041031_?)del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.(?_123025068)_(123041031_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000023.10:g.(?_123025068)_(123041031_?)del AND X-linked lymphoproliferative disease due to XIAP deficiency" Accession="RCV004580149" Version="1">
        <ClassifiedConditionList TraitSetID="3179">
          <ClassifiedCondition DB="MedGen" ID="C1845076">X-linked lymphoproliferative disease due to XIAP deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-03-23" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-06-30" MostRecentSubmission="2024-06-29">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="3179" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2711" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Lymphoproliferative syndrome 2, X-linked</ElementValue>
                <XRef ID="X-linked+lymphoproliferative+syndrome+2/9494" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">X-linked lymphoproliferative disease due to XIAP deficiency</ElementValue>
                <XRef ID="MONDO:0010385" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">XIAP DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="300635" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">XLP2</ElementValue>
                <XRef Type="MIM" ID="300635" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">XIAP-Related Lymphoproliferative Disease, X-Linked</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10916" />
                <XRef ID="10916" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">X-linked lymphoproliferative disease (XLP) has two recognizable subtypes, XLP1 and XLP2. XLP1 is characterized predominantly by one of three commonly recognized phenotypes: Inappropriate immune response to Epstein-Barr virus (EBV) infection leading to hemophagocytic lymphohistiocytosis (HLH) or severe mononucleosis. Dysgammaglobulinemia. Lymphoproliferative disease (malignant lymphoma). XLP2 is most often characterized by HLH (often associated with EBV), dysgammaglobulinemia, and inflammatory bowel disease. HLH resulting from EBV infection is associated with an unregulated and exaggerated immune response with widespread proliferation of cytotoxic T cells, EBV-infected B cells, and macrophages. Dysgammaglobulinemia is typically hypogammaglobulinemia of one or more immunoglobulin subclasses. The malignant lymphomas are typically B-cell lymphomas, non-Hodgkin type, often extranodal, and in particular involving the intestine.</Attribute>
                <XRef ID="NBK1406" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301580</ID>
                <ID Source="BookShelf">NBK1406</ID>
              </Citation>
              <XRef ID="2442" DB="Orphanet" />
              <XRef ID="538934" DB="Orphanet" />
              <XRef ID="C1845076" DB="MedGen" />
              <XRef ID="MONDO:0010385" DB="MONDO" />
              <XRef Type="MIM" ID="300635" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9835075" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-29" DateCreated="2024-06-29">
        <ClinVarSubmissionID localKey="NC_000023.10:g.(?_123025068)_(123041031_?)del|MedGen:C1845076" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005062658" DateUpdated="2024-06-29" DateCreated="2024-06-29" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the XIAP protein in which other variant(s) (p.Gln440*) have been determined to be pathogenic (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with XIAP-related conditions. This variant is a gross deletion of the genomic region encompassing exon(s) 4-7 of the XIAP gene, which includes the termination codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. While this deletion is not anticipated to lead to nonsense mediated decay, it is expected to alter mRNA translation or result in a truncated protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.(?_123025068)_(123041031_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1845076" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14505471</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9835075" TraitType="Disease" MappingType="XRef" MappingValue="C1845076" MappingRef="MedGen">
        <MedGen CUI="C1845076" Name="X-linked lymphoproliferative disease due to XIAP deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

